本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Artelo Biosciences, Inc.

1.27
-0.0200-1.55%
盤後1.25-0.0192-1.51%19:41 EDT
成交量:22.00萬
成交額:27.85萬
市值:442.66萬
市盈率:-0.05
高:1.33
開:1.31
低:1.20
收:1.29
52周最高:85.80
52周最低:1.19
股本:348.55萬
流通股本:223.29萬
量比:0.74
換手率:9.85%
股息:- -
股息率:- -
每股收益(TTM):-28.0229
每股收益(LYR):-54.8768
淨資產收益率:-367.70%
總資產收益率:-91.33%
市淨率:0.66
市盈率(LYR):-0.02

資料載入中...

2026/05/27

重要事件披露

Form 8-K - Current report
2026/05/15

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/14

SEC問詢函

Form CORRESP - Correspondence
2026/04/07

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/04/07

重要事件披露

Form 8-K - Current report
2026/04/03

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/30

重要事件披露

Form 8-K - Current report
2026/03/26

重要事件披露

Form 8-K - Current report
2026/03/26

SEC問詢函

Form CORRESP - Correspondence
2026/03/24

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/03/24

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/03/23

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/03/21

SEC問詢函

Form CORRESP - Correspondence
2026/03/21

SEC問詢函

Form CORRESP - Correspondence
2026/03/20

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/03/19

重要事件披露

Form 8-K - Current report
2026/03/17

重要事件披露

Form 8-K - Current report
2026/03/06

重要事件披露

Form 8-K - Current report